Tenofovir-DF versus Hydroxychloroquine in the Treatment of Hospitalized Patients with COVID-19: An Observational Study (TEDHICOV)

Mario Cornejo-Giraldo, Nelson Rosado, Jesús Salinas, Nelson Aspilcueta, Eduardo Bernales, Jimmy Lipa, Johanna Coacalla, Yoisi Flores, Pamela Leon, Claudia Chambi
doi: https://doi.org/10.1101/2021.03.24.21252635

Article Information

doi 
https://doi.org/10.1101/2021.03.24.21252635
History 
  • March 26, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Mario Cornejo-Giraldo1,2,*,
  2. Nelson Rosado1,2,
  3. Jesús Salinas1,2,
  4. Nelson Aspilcueta1,
  5. Eduardo Bernales1,
  6. Jimmy Lipa1,
  7. Johanna Coacalla1,
  8. Yoisi Flores1,
  9. Pamela Leon1 and
  10. Claudia Chambi1
  1. 1Hospital Nacional Carlos Alberto Seguín Escobedo (CASE)-EsSalud, Arequipa, Perú
  2. 2Universidad Católica de Santa María, Arequipa, Perú
  1. ↵*Correspondence: Mario Cornejo-Giraldo, Esquina Peral / El Filtro S/N, Arequipa, Perú. e-mail: mariocg40{at}gmail.com
Back to top
Posted March 26, 2021.
Download PDF
Data/Code
Email
Tenofovir-DF versus Hydroxychloroquine in the Treatment of Hospitalized Patients with COVID-19: An Observational Study (TEDHICOV)
Mario Cornejo-Giraldo, Nelson Rosado, Jesús Salinas, Nelson Aspilcueta, Eduardo Bernales, Jimmy Lipa, Johanna Coacalla, Yoisi Flores, Pamela Leon, Claudia Chambi
medRxiv 2021.03.24.21252635; doi: https://doi.org/10.1101/2021.03.24.21252635
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area